In this article, we will look at the 8 Most Oversold Strong Buy-Rated Stocks to Invest In.

Cancer innovation advances in many ways, but real impact depends on the ability to translate progress into care that is ...

New technology designed to provide a single irrigation management system for ureteroscopy, cystoscopy, percutaneous ...

The biggest names in cardiology tech gathered in New Orleans for the American College of Cardiology (ACC) Scientific Sessions ...

Boston Scientific (BSX) stock tumbled 9% to two-year lows after Watchman trial data revealed stroke concerns and Raymond ...

CHAMPION-AF shows Boston Scientific's Watchman FLX as a safe, effective first-line option for stroke risk reduction in ...

Data for Boston Scientific’s Watchman FLX implant met the primary endpoint in a new study. The stock is falling anyway.

Boston Scientific stock tumbled Monday on mixed test results for its Watchman device in patients at risk of having a stroke.

Boston Scientific (BSX) stock plummeted 8% after Raymond James downgraded the company and lowered its price target to $88 on slowing growth in key segments.

In one of the largest studies of its kind, a trial of Boston Scientific’s small, permanent cardiac implant showed that it could potentially serve as an alternative to long-term blood thin | Boston ...

Boston Scientific Corp’s stock recently traded at $65.26, hovering near its 52-week low of $67.56, underscoring a challenging year for the medical device company with a market c ...

For patients with non-valvular atrial fibrillation (AFib) who had no contraindications to taking oral anticoagulants, the use of a device to close off the left atrial appendage in the heart—a small ...